Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative-intent resection of pancreatic cancer: a multicentre randomised controlled trial

Trial Profile

Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative-intent resection of pancreatic cancer: a multicentre randomised controlled trial

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2014

At a glance

  • Drugs Gemcitabine (Primary)
  • Indications Pancreatic cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 03 Jun 2014 Results for the predictive value of human equilibrative nucleosid transporter 1 (hent1) expression presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
    • 09 Oct 2013 Primary endpoint 'Disease-free-survival-duration' has been met according to results published in the JAMA: the Journal of the American Medical Association.
    • 09 Oct 2013 Results published in the JAMA: the Journal of the American Medical Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top